These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7595090)

  • 1. Association of synthetic peptide fragments of human apolipoprotein A-I with phospholipids.
    Vanloo B; Demoor L; Boutillon C; Lins L; Brasseur R; Baert J; Fruchart JC; Tartar A; Rosseneu M
    J Lipid Res; 1995 Aug; 36(8):1686-96. PubMed ID: 7595090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformation and lipid binding of the N-terminal (1-44) domain of human apolipoprotein A-I.
    Zhu HL; Atkinson D
    Biochemistry; 2004 Oct; 43(41):13156-64. PubMed ID: 15476409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-binding properties of synthetic peptide fragments of human apolipoprotein A-II.
    Benetollo C; Lambert G; Talussot C; Vanloo E; Cauteren TV; Rouy D; Dubois H; Baert J; Kalopissis A; Denèfle P; Chambaz J; Brasseur R; Rosseneu M
    Eur J Biochem; 1996 Dec; 242(3):657-64. PubMed ID: 9022694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation and lipid binding of a C-terminal (198-243) peptide of human apolipoprotein A-I.
    Zhu HL; Atkinson D
    Biochemistry; 2007 Feb; 46(6):1624-34. PubMed ID: 17279626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic model peptides for apolipoproteins. II. Characterization of the discoidal complexes generated between phospholipids and synthetic model peptides for apolipoproteins.
    Corijn J; Deleys R; Labeur C; Vanloo B; Lins L; Brasseur R; Baert J; Ruysschaert JM; Rosseneu M
    Biochim Biophys Acta; 1993 Sep; 1170(1):8-16. PubMed ID: 8399330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional properties of the 154-171 wild-type and variant peptides of human lecithin-cholesterol acyltransferase.
    Peelman F; Goethals M; Vanloo B; Labeur C; Brasseur R; Vandekerckhove J; Rosseneu M
    Eur J Biochem; 1997 Nov; 249(3):708-15. PubMed ID: 9395317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the discoidal complexes formed between apoA-I-CNBr fragments and phosphatidylcholine.
    Vanloo B; Morrison J; Fidge N; Lorent G; Lins L; Brasseur R; Ruysschaert JM; Baert J; Rosseneu M
    J Lipid Res; 1991 Aug; 32(8):1253-64. PubMed ID: 1770308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of central alpha-helices in human apolipoprotein A-I: effect on phospholipid association.
    Frank PG; Bergeron J; Emmanuel F; Lavigne JP; Sparks DL; Denèfle P; Rassart E; Marcel YL
    Biochemistry; 1997 Feb; 36(7):1798-806. PubMed ID: 9048564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-I adopts a belt-like orientation in reconstituted high density lipoproteins.
    Panagotopulos SE; Horace EM; Maiorano JN; Davidson WS
    J Biol Chem; 2001 Nov; 276(46):42965-70. PubMed ID: 11557764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composition and structural and functional properties of discoidal and spherical phospholipid-apoE3 complexes.
    De Pauw M; Vanloo B; Dergunov AD; Devreese AM; Baert J; Brasseur R; Rosseneu M
    Biochemistry (Mosc); 1997 Mar; 62(3):251-63. PubMed ID: 9275298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of lipid-binding properties of the N-terminal helical segments in human apolipoprotein A-I using fragment peptides.
    Tanaka M; Tanaka T; Ohta S; Kawakami T; Konno H; Akaji K; Aimoto S; Saito H
    J Pept Sci; 2009 Jan; 15(1):36-42. PubMed ID: 19048603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.
    Labeur C; Lins L; Vanloo B; Baert J; Brasseur R; Rosseneu M
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):580-8. PubMed ID: 9102180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes.
    Mishra VK; Palgunachari MN; Datta G; Phillips MC; Lund-Katz S; Adeyeye SO; Segrest JP; Anantharamaiah GM
    Biochemistry; 1998 Jul; 37(28):10313-24. PubMed ID: 9665740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of single amino acid E235 affects the structure and lipid interaction of human apolipoprotein A-I C-terminal peptides.
    Tanaka T; Tanaka M; Sugiura M; Kawakami T; Aimoto S; Saito H
    Chem Pharm Bull (Tokyo); 2009 May; 57(5):499-503. PubMed ID: 19420782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-binding studies of human apolipoprotein A-I and its terminally truncated mutants.
    Fang Y; Gursky O; Atkinson D
    Biochemistry; 2003 Nov; 42(45):13260-8. PubMed ID: 14609337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly.
    Palgunachari MN; Mishra VK; Lund-Katz S; Phillips MC; Adeyeye SO; Alluri S; Anantharamaiah GM; Segrest JP
    Arterioscler Thromb Vasc Biol; 1996 Feb; 16(2):328-38. PubMed ID: 8620350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the C-terminal helix by single amino acid deletion is directly responsible for impaired cholesterol efflux ability of apolipoprotein A-I Nichinan.
    Kono M; Tanaka T; Tanaka M; Vedhachalam C; Chetty PS; Nguyen D; Dhanasekaran P; Lund-Katz S; Phillips MC; Saito H
    J Lipid Res; 2010 Apr; 51(4):809-18. PubMed ID: 19805625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the hydrophobicity gradient of an amphipathic peptide to its mode of association with lipids.
    Pérez-Méndez O; Vanloo B; Decout A; Goethals M; Peelman F; Vandekerckhove J; Brasseur R; Rosseneu M
    Eur J Biochem; 1998 Sep; 256(3):570-9. PubMed ID: 9780233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.
    Davidson WS; Lund-Katz S; Johnson WJ; Anantharamaiah GM; Palgunachari MN; Segrest JP; Rothblat GH; Phillips MC
    J Biol Chem; 1994 Sep; 269(37):22975-82. PubMed ID: 8083197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the lipid-free structure and stability of apolipoprotein A-I by mutation.
    Gorshkova IN; Liadaki K; Gursky O; Atkinson D; Zannis VI
    Biochemistry; 2000 Dec; 39(51):15910-9. PubMed ID: 11123918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.